- Home
- BXP vs BAX Comparison
BXP vs BAX Comparison
Compare BXP & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BXP | BAX |
|---|---|---|
| Founded | 1970 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.2B |
| IPO Year | 1998 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BXP | BAX |
|---|---|---|
| Price | $52.75 | $17.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 9 |
| Target Price | ★ $73.58 | $22.38 |
| AVG Volume (30 Days) | 2.7M | ★ 9.4M |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.29% | 0.23% |
| EPS Growth | ★ 1833.33 | N/A |
| EPS | ★ 1.74 | N/A |
| Revenue | $3,482,279,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $10.94 | $1.90 |
| Revenue Next Year | $3.00 | $2.09 |
| P/E Ratio | $30.50 | ★ N/A |
| Revenue Growth | 2.19 | ★ 5.72 |
| 52 Week Low | $52.82 | $17.40 |
| 52 Week High | $79.33 | $36.57 |
Technical Indicators
Market Signals| Indicator | BXP | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 27.14 | 34.45 |
| Support Level | N/A | $17.69 |
| Resistance Level | $73.29 | $19.31 |
| Average True Range (ATR) | 2.01 | 0.78 |
| MACD | -0.60 | -0.38 |
| Stochastic Oscillator | 19.10 | 16.75 |
Price Performance
Historical ComparisonAbout BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.